Axiom Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Axiom Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37K	Hold	25,375	–	–	﹤0.01%	452
2026 Q1	$6.26K	Buy	+25,375	New	+$10.1K	﹤0.01%	337
2022 Q4	–	Sell	-8,000	Closed	-$38K	–	366
2022 Q3	$38K	Buy	+8,000	New	+$41.1K	0.08%	185

Other funds holding SGMO

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Axiom Investment Management's SGMO Position: Q2 2026 in Review

Axiom Investment Management held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q2 2026 at 25,375 shares worth $1.37K. The position accounts for ﹤0.01% of the portfolio, ranked #452.

Axiom Investment Management first reported a position in SGMO in Q3 2022 and has held it in 3 quarters since. The position peaked at $38K in Q3 2022. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Axiom Investment Management held 25,375 shares of SANGAMO THERAPEUTICS INC worth $1.37K as of Q2 2026.
Axiom Investment Management left its SANGAMO THERAPEUTICS INC share count unchanged in Q2 2026.
SANGAMO THERAPEUTICS INC made up ﹤0.01% of Axiom Investment Management's portfolio in Q2 2026, its #452 holding.
Axiom Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q3 2022 and has held it in 3 quarters since.
Axiom Investment Management's SANGAMO THERAPEUTICS INC position peaked at $38K in Q3 2022.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.